Iovance Biotherapeutics Inc (IOVA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt IOVA? Forum Prognose Aktiensplit

Finanzdaten der Iovance Biotherapeutics Inc-Aktie (IOVA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	48.34% 0.715	0.482	0.469	0.238	-
Cost Of Revenue	66.35% 7.261	4.365	4.34	2.05	-
Gross Profit	68.58% -6.546	-3.883	-3.871	-1.812	-
Operating Expenses	5.28% 111.18	117.37	114.49	108.27	110.86
Benefits Costs and Expenses	2.97% 115.10	118.62	115.47	107.24	107.37
Costs And Expenses	2.71% 118.44	121.74	118.83	110.32	110.86
Operating Income/Loss	2.91% -117.72	-121.26	-118.36	-110.09	-110.86
Income/Loss From Continuing Operations Before Tax	3.18% -114.38	-118.14	-115.00	-107.00	-107.37
Income Tax Expense/Benefit, Deferred	19.95% -1.408	-1.759	-1.243	-	-
Income Tax Expense/Benefit	19.95% -1.408	-1.759	-1.243	-0.477	-
Income/Loss From Continuing Operations After Tax	2.92% -112.98	-116.38	-113.76	-106.53	-107.37
Net Income/Loss	2.92% -112.98	-116.38	-113.76	-106.53	-107.37
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	216.82% 266.22	-227.88	245.82	224.48	213.69
Diluted Average Shares	216.82% 266.22	-227.88	245.82	224.48	213.69
Basic Earnings Per Share	6.67% -0.42	-0.45	-0.46	-0.47	-0.50
Diluted Earnings Per Share	6.67% -0.42	-0.45	-0.46	-0.47	-0.50
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%